title: Schizophrenia: more dopamine, more D2 receptors.
authors.affiliation: Departments of Psychiatry and Pharmacology, University of Toronto, Toronto, ON Canada M5S 1A8. philip.seeman@utoronto.ca
authors.forename: P
authors.initials: P
authors.lastname: Seeman
authors.forename: S
authors.initials: S
authors.lastname: Kapur
mesh_terms: D001549:Benzamides / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism*; D018492:Dopamine Antagonists / Q000378:metabolism; D008954:Models, Biological; D011618:Psychotic Disorders / Q000209:etiology*; D011759:Pyrrolidines / Q000378:metabolism; D017448:Receptors, Dopamine D2 / Q000378:metabolism*; D012559:Schizophrenia / Q000209:etiology*
chemical_list: D001549:Benzamides; D018492:Dopamine Antagonists; D011759:Pyrrolidines; D017448:Receptors, Dopamine D2; C055743:3-iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide; D004298:Dopamine